VNRX
VolitionRx Limited
stockNYSEAMERICAN
volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx's development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.21 | 2026-10-09 | -14.58% | 2.428 |
| 1M | 0.28 | 2026-09-17 | -36.64% | 2.900 |
| 3M | 1.10 | 2026-07-17 | -83.59% | 3.228 |
| 6M | 3.58 | 2026-04-17 | -94.95% | 2.742 |
| 1Y | 8.88 | 2025-10-17 | -97.97% | 1.346 |
| 2Y | 14.60 | 2024-10-17 | -98.76% | — |
| 5Y | 68.20 | 2021-10-18 | -99.73% | 0.774 |
VolitionRx Limited (NYSEAMERICAN:VNRX) stock price today is $0.18, and today's volume is 492,733. VNRX is down 4.244% today. The 30 day average volume is 2.65M. VNRX market cap is $5.43M with 30.06M shares outstanding.